Despite considerable advances, both the central regulation of erection with processing of various stimuli, and the different steps involved in neurotransmission, impulse propagation and intracellular transduction of neural signals in penile smooth muscles, are still incompletely known. Centrally as well as peripherally, many transmitters and transmitter systems are involved. Dopamine, nitric oxide, oxytocin and ACTH=a-MSH, seem to have a facilitatory role, whereas serotonin may be either facilitatory or inhibitory, and enkephalins are inhibitory. Peripherally, the balance between contractant (eg noradrenaline, endothelins, angiotensins) and relaxant (eg NO, VIP and related peptides, prostanoids) factors controls the degree of contraction of the smooth muscle of the corpora cavernosa, and determines the functional state of the penis. Neurogenic NO is considered the most important factor for relaxation of penile vessels and corpus cavernosum. The roles of other putative transmitters=mediators and of various intracellular mechanisms, producing relaxation of vascular and corpus cavernosum smooth muscle, have not been established. For example, recent findings have suggested a role of Rho=Rho-kinase in the regulation of cavernosal tone, and that Rho-kinase antagonism could be a new potential principle for the treatment of erectile dysfunction. Further research in this area may be rewarding.
Introduction
Basically, erection is a reflex initiated by recruitment of penile afferents, which after central processing and integration involves both autonomic and somatic efferents. The reflex is mediated at the spinal cord level and modulated by supraspinal influences. The central regulation of penile erection with processing and integration of different stimuli (Figure 1 ), involves many transmitters and transmitter systems, the details of which are still incompletely known. Peripherally, the local balance between contractant and relaxant factors controls the degree of contraction of the smooth muscle of the corpora cavernosa, and determines the functional state of the penis: detumescence and flaccidity, and tumescence and erection, respectively. The details of the different steps involved in neurotransmission, impulse propagation and intracellular transduction of neural signals in penile smooth muscles remain to be elucidated.
Several aspects on the central and peripheral control of penile erection have been extensively reviewed previously. 1 -7 A brief updating of some of this information is given below.
Central neuromediation
The central mechanisms controlling erection include supraspinal as well as spinal pathways. Some of the anatomical areas of the brain that relate to sexual function have been defined, including the medial amygdala, medial pre-optic area (MPOA), paraventricular nucleus (PVN), the periaqueductal grey and ventral tegmentum. 8 Studies in rats have revealed that electrical stimulation of the MPOA, 9 the PVN, 10 or the hippocampal formation 11 can elicit an erectile response.
Spinally, there seems to be a network consisting of primary afferents from the genitals, spinal interneurons and sympathetic, parasympathetic and somatic nuclei. This network appears capable of integrating information from the periphery and eliciting reflexive erections, and also, probably including additional populations of spinal interneurons, to be the recipient of supraspinal information. 12 There is evidence from spinalized animals that erections can be elicited from a spinal site of action. 13, 14 Evidence is accumulating, suggesting that oxytocin, dopamine, serotonin and nitric oxide (NO) have important roles in various aspects of sexual function, 6, 8 both supraspinally and spinally.
Oxytocin
Hypothalamic supraoptic and paraventricular nuclei project to spinal centers influencing erectile function. 2 The oxytocinergic spinal projections from these regions are likely to influence sacral autonomic rather than the somatic outflow. 15 Immunoreactive oxytocin-containing spinal neurons associating with sacral preganglionic neurons have been demonstrated. This observation, confirmed by retrograde labelling, supports the role of oxytocin in the autonomic spinal circuitry that mediates penile erection. 16, 17 When injected into the lateral cerebral ventricle, the PVN, or hippocampus of laboratory animals, oxytocin is a potent inducer of penile erection. However, intrathecal (i.t.) oxytocin can also initiate an erection. These erectile responses can be blocked by the administration of oxytocin antagonists given intracerebroventricularly (i.c.v.) or i.t., or by electrolytic lesion of the PVN. Also, non-contact erections were reduced dose-dependently by a selective oxytocin receptor antagonist, given into the lateral ventricles, supporting the view that oxytocin mediates this response. 18 The oxytocinergic system may be influenced by the NO synthase signal transduction pathway. Thus, oxytocin increases NO production in the PVN. 19 Furthermore, inhibitors of this pathway prevent penile erection and yawning in rats induced by oxytocin, and also by dopamine, excitatory amino acids, the 5-HT 2C receptor agonist, m-chlorophenylpiperazine (m-CCP; trazodone metabolite), and ACTH=a-MSH (Figure 2 ).
The relevance of the oxytocinergic pathway has never been demonstrated in humans, even if plasma oxytocin concentrations are known to be elevated following sexual stimulation. 2 However, the therapeutic potential of the system remains to be explored.
Dopamine
Central dopaminergic neurons comprise an incertohypothalamic system with projections to the MPOA and PVN. 20 Dopaminergic neurons have also been identified, travelling from the caudal hypothalamus within the diencephalospinal dopamine pathway to innervate the lumbosacral spinal cord. 21, 22 Thus, dopamine can be expected to participate in the central regulation of both the autonomic and somatic components of the penile reflexes. Supporting this view, the dopamine receptor agonist, apomorphine, administered systemically to male rats, was found to induce penile erection, 23 simultaneously producing yawning and seminal emission. The effect of apomorphine was biphasic in the freely moving rat, low doses facilitating and high doses inhibiting, erection. 24 Also low dose systemic administration of other dopamine agonists such as piribedil, lisuride and quinelorane to rats and other animals initiates erection (for a review, see reference 2). The effects of these agonists were attenuated by centrally, but not peripherally, acting dopamine receptor antagonists.
Both the two major families of dopamine receptors, D 17 and D 27 like receptors, 25 Figure 1 Penile erection is basically a spinal reflex controlled supraspinally, where erectile stimuli can be generated in response to visual, olfactory and imaginative stimuli. stimulation, via D 1 receptors in particular, facilitated erections. 26 In contrast, dopaminergic antagonists injected into the MPOA decreased the number of penile reflexes. 24, 27 In the PVN, similar experiments have established that D 2 rather than D 1 receptors primarily facilitate erections. 2 The erection following paraventricular D 2 receptor stimulation apparently involves oxytocinergic neurotransmission. Dopaminergic neurons impinge on oxytocinergic cell bodies in the PVN, 28, 29 and apomorphine-induced penile erection is prevented dose-dependently by oxytocin receptor antagonists, 30 or by electrolytic lesions of the PVN that deplete central oxytocin content. 31 -33 Conversely, injection of oxytocin into the PVN induced erections that were not attenuated by dopamine receptor blockade, suggesting that dopaminergic neurons activate oxytocinergic neurons in the PVN, and that released oxytocin then accounts for the erectile response.
Erection Erection Erection
Injection of apomorphine into the lumbosacral subarachnoid space was reported to impair ex copula penile reflexes, slow the rate of copulation and decrease the number of intromissions preceding ejaculation, 34, 35 suggesting an inhibitory effect on spinal erectile mechanisms. This is in contrast to recent findings showing that injection of apormorphine intrathecally in rats evoked erection in both normal and spinalized animals. 13, 14 The difference in result is difficult to explain. However, most probably, stimulation of the dopaminergic system can produce erection both at supraspinal and spinal sites.
As mentioned above, systemically administered apomorphine enhances seminal emission. Pehek et al found that apomorphine injected into the PVN, but not in the the MPOA, enhanced seminal emission. 34 Recording of intravesical pressure in the non-anaesthetized rat after administration of apomorphine showed that the pressure response consisted of both smooth and striated muscle components. 36 This implies that apomorphine has effects not only on the sacral parasympathetic output, but also on somatic pathways. Systemically administered apomorphine induces both penile erection and bladder overactivity in male rats. 37 Thus, at least in rats, apomorphine has effects not only on erection, but also on seminal emission and bladder function. The selectivity of apomorphine for dopamine receptor subtypes is shown in Table 2 .
Serotonin
Serotonin (5-hydroxytryptamine, 5-HT) is present in supraspinal as well as spinal and peripheral sites believed to be involved in sexual behaviour. Neurons containing 5-HT can be found in the medullary raphe nuclei and ventral medulla reticular formation, including the rostral nucleus paragigantocellularis. Bulbospinal neurons containing 5-HT project to the lumbar spinal cord in the rat and cat. 2 Fibres immunoreactive for serotonin have been shown to be distributed in the dorsal horn, the dorsal grey commissure, the sacral parasympathetic nucleus, and the ventral horn. Some serotonergic fibres occurred in close apposition with retrogradely-labelled sacral preganglionic neurons and motoneurons, and synapses were demonstrated at the ultrastructural level. 15 The morphological findings support involvement in the spinal pharmacology of erectile function with participation in both sympathetic and parasympathetic outflow mechanisms. In animals, 5-HT pathways seem to exert a general inhibitory effect on 42 These findings suggest that both oxytocin and NO are involved in 5-HT 2C -receptor mediated responses. Thus, 5-HT appears to serve various functions in male sexual function and probably acts as a major modulator of the central neuroregulatory control of penile erection.
ACTH and related peptides
The adrenocorticotropic (ACTH) and a-melanocyte stimulating hormones (a-MSH), have both been associated with erectile responses. Administered i.c.v., these peptides are able to induce penile erection along with grooming, stretching and yawning. 43 Most, if not all, of the effects of the a-MSH=ACTH peptides are mediated via melanocortin (MC) receptors of which five different subtypes have been cloned and characterized. 44, 45 a-MSH=ACTH peptides seem to act in the hypothalamic preventricular region, and grooming, stretching and yawning, but not penile erection, appear to be mediated by MC 4 receptors. 43, 46 Interestingly, the MC 3 receptor showed a high density in the hypothalamus and limbic systems, 44, 45 regions known to be important for erectile functions. The site or mechanism of action responsible for ACTHinduction of erection is different from that involving dopamine or oxytocin action in the PVN. 3 A synthetic analogue of a-MSH, Melanotan II, given subcutaneously, had proerectile effects in men with psychogenic impotence. 47 However, the therapeutic potential of a-MSH analogues remains to be established.
Excitatory amino acids
Excitatory amino acids appear to exert a role in penile erection. Thus, microinjections of L-glutamate into the MPOA elicited an increase in intracavernous pressure, 9 and behavioural studies have shown that N-methyl-D-aspartate (NMDA) increases the number of penile erections when injected into the PVN. 48, 49 NMDA, amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) or trans-1-amino-1,3-cyclo-pentadicarboxylic acid (ACPD) increased intracavernous pressures when injected into the PVN. 50 The effect of NMDA was prevented by i.c.v. administration of an oxytocin antagonist. 48 The NO synthase signal transduction pathway is considered to mediate the effect of NMDA (Figure 2) , since the administration of NOS inhibitors into the PVN and i.c.v., blocked the NMDA effect. 51, 52 Further support was provided by findings that NMDA injected into the PVN also leads to an increased concentration of NO metabolites in this region. 52 
Noradrenaline
Evidence for noradrenergic effects in the central neuromediation of penile erection is sparse. However, the current data suggest that increased noradrenergic activity stimulates, whereas decreased noradrenergic activity inhibits, sexual function. 38, 53, 54 Gamma-amino butyric acid Cumulative data resulting from investigations on the role of gamma-amino butyric acid (GABA) in penile erection indicate that this neurotransmitter may function as an inhibitory modulator in the autonomic and somatic reflex pathways involved in penile erection. 1 Recent investigations showed that activation of GABA(A) receptors in the PVN reduced apomorphine-, N-methyl-D-aspartic acid-(NMDA), and oxytocin-induced penile erection and yawning in male rats. 55 
Opioid peptides
Available information supports the hypothesis that opioid m receptor stimulation centrally prevents penile erection by inhibiting mechanisms that converge upon central oxytocinergic neurotransmission. 2 In rats, morphine injected into the PVN prevented non-contact penile erections and impaired copulation. These effects of morphine are apparently mediated by a prevention of the increased NO production that occurs in the PVN during sexual activity. 56 Morphine also prevents apomorphine-oxytocin-, NMDA-and non-contactinduced penile erection and yawning by inhibiting NO synthase activity in the PVN. 56 -59 
Nitric oxide
Evidence is accumulating that is the CNS, NO function is essential for erectile responses ( Figure  2 ). NO can modulate sexual behaviour and penile erection, 60 -64 and may act in several discrete brain regions, eg in the MPOA 63, 64 and the PVN. 10, 61 As mentioned previously, injection of NOS inhibitors i.c.v. or in the PVN prevented penile erectile responses induced by dopamine agonists, oxytocin, and NMDA in rats. NO may also mediate the actions of ACTH=a-MSH and 5-HT 2C agonists, which elicit erections when injected into the i.c.v. system, according to mechanisms unrelated to oxytocinergic neurotransmission. 61 The inhibitory effect of NOS inhibitors was not observed when these compounds were injected concomitantly with L-arginine, the substrate for NO. 61 NO production increased in the PVN of male rats during non-contact penile erections and copulation, confirming that NO is a physiological mediator of penile erection at the level of the PVN. 62 
Peripheral neuromediation
The different structures of the penis receive sympathetic, parasympathetic, somatic and sensory innervation. 2, 65 The nerves contain different transmitters, and the nerve populations have been categorized as adrenergic, cholinergic, and non-adrenergic, noncholinergic (NANC). It should be stressed that these nerve categories may contain more than one transmitter or transmitter=modulator generating enzymes, such as NOS and heme oxygenases (HO). Thus, it seems that one important population of nerves in the corpora cavernosa contains not only acetylcholine, but also NOS, VIP, and neuropeptide Y. 66, 67 The nerves and vasculature of the penis produce and release transmitters and modulators, producing contraction or relaxation. These transmitters= modulators interact in their control of the contractile state of the corpus cavernosum smooth muscle. In addition they may also have other important functions, some of which are discussed below.
Noradrenaline and a-adrenoceptors
It is generally accepted that the penis is kept in the flaccid state mainly via a tonic activity in adrenergic nerves through release of noradrenaline (NA). 6 NA stimulates a-adrenoceptors (ARs) in the penile vasculature contracting the helicine vessels, and in the corpus cavernosum, contracting the trabecular smooth muscle. 2 Androgens may regulate the a-AR responsiveness of cavernous smooth muscle. Compared to normal rats, castrated animals showed an enhanced reactivity to a 1 -AR stimulation. 68 Both a 1 and a 2 -ARs have been demonstrated in human corpus cavernosum tissue, but available information supports the view of a functional predominance of a 1 -ARs. This may be the case also in the penile vasculature, although a contribution of a 2 -ARs to the contraction induced by NA and electrical stimulation of nerves cannot be excluded. 2 The subtypes of a 1 -AR with high affinity for prazosin, a 1A , a 1B and a 1D have been demonstrated in human corporal tissue, using receptor binding and isometric tension experiments, and their mRNAs have been identified, the a 1A -and a 1D -ARs predominating. The NA-induced contraction in this tissue may be mediated by two or possibly three receptor subtypes. 6 An additional a 1 -AR subtype with low affinity for prazosin (a 1L ), which probably represents a conformational state of the a 1A -AR, has been demonstrated in, eg vascular smooth muscle. The possibility that the a 1L -AR subtype may be of importance in human penile erectile tissues was recently suggested. 69 In rats, a 1B -and a 1L -AR subtypes seem functionally relevant for erectile function, and a 1B -and=or a 1L -AR subtype selective antagonists were suggested to represent advantages in the treatment of erectile dysfunction. 70 However, the distribution of a 1 -AR subtypes in the penis and systemic vasculature may not be the same in rats and humans, and the method of study may influence the results. For example, in vitro, Hussain and Marshall found that the a 1D -AR predominated in several systemic rat vessels, 71 which may not be the case in humans. 72 Tong and Cheng found a 1A -ARs to be responsible for the contractile response of rat corpus cavernosum, 73 which does not seem to be in agreement with the in vivo data.
Expression of mRNA for a 2A -, a 2B -and a 2C -ARs in whole human corpus cavernosum tissue has been demonstrated. Radioligand binding revealed specific a 2 -AR binding sites, and functional experiments showed that the selective a 2 -AR agonist, UK 14 304, induced concentration-dependent contractions of isolated strips of human corpus cavernosum smooth muscle. 74 Whether or not these a 2 -ARs are of importance for the contractile regulation of tone in corpus cavernosum smooth muscle is still unclear. Prejunctional a 2 -ARs have been shown to modulate stimulus-evoked release of NA from nerves in the human corpus cavernosum, stimulation inhibiting release of the amine. However, stimulation of prejunctional a 2 -ARs in horse penile resistance arteries was shown also to inhibit NANC-transmitter release. 75 This might be one of the mechanisms by which NA maintains detumescence.
Endothelins and endothelin receptors
Endothelins (ETs) have been demonstrated in penile erectile tissues and suggested to contribute to the 2 Contractions can be evoked in human corpus cavernosus tissue also by ET-2 and ET-3, although these peptides have a lower potency than ET-1. 76 The contractions induced by ET-1 may be dependent on both transmembrane calcium flux (through voltage-dependent and=or receptor-operated calcium channels) and on the mobilization of inositol trisphosphate-(IP 3 -) sensitive intracellular calcium stores. ET-1 may function not only as a long-term regulator of corporal smooth muscle tone, but also as modulator of the contractile effect of other agents, eg NA, or as a modulator of cellular proliferation and phenotypic expression.
Even if much available in vitro information suggests that ETs may be of importance for erectile physiology and pathophysiology, the role of the peptides in vivo is unclear.
Acetylcholine and cholinergic receptors
The importance of parasympathetic nerves for producing penile erection has been well established. 2 Penile tissues from humans and several animal species are rich in cholinergic nerves. 65 -67 From these nerves, ACh can be released by transmural electrical field stimulation. In isolated corpus cavernosum cells, carbachol consistently produced contraction. This means that relaxation induced by ACh can be obtained either by inhibition of release of a contractant factor, eg NA, and=or is produced by the release of a relaxation-producing factor, eg NO.
It is important to stress that parasympathetic activity is not equivalent with the actions of ACh; other transmitters may be released from cholinergic nerves. 66, 67 Parasympathetic activity may produce penile tumescence and erection by inhibiting the release of NA through stimulation of muscarinic receptors on adrenergic nerve terminals, and=or by releasing NO and eg vasodilating peptides from nerves and endothelium.
Nitric oxide and the guanylate cyclase=cGMP pathway
An important role for NO in the relaxation of corpus cavernosum smooth muscle and vasculature is widely accepted. 2, 77 In vitro, several investigators have shown that both acetylcholineand neuronally mediated relaxation in animal and human corpus cavernosum involves release of NO, or a NO-like substance. 2 Both the endothelium and=or the nerves innervating the corpus cavernosum may be the source of the NO, and thus, more than one isoform of NOS can be involved.
Mice lacking nNOS have erections, show normal mating behaviour, and respond with erection to electrical stimulation of the cavernous nerves. 78 Surprisingly, isolated corporal tissue from both wild type and nNOS-deleted animals showed similar responses to electrical stimulation. It was suggested that eNOS is essential for erection, not only in nNOS deleted, but also in normal mice. eNOS is expressed in cavernosal smooth muscle and could be a main source of NO alongside nNOS. However, it was shown that mice carrying a mutation in the nNOS gene are still able to express an alternatively spliced mRNA of nNOS, which could be the source of NO in nNOS mutant mice. 79 Since NO is produced, the guanylyl=cGMP=cGKI pathway apparently is intact in the corpus cavernosum of these animals.
cGMP signals via three different receptors in eukaryotic cells, including ion channels, phosphodiesterases and protein kinases. At present, however, the molecular targets which are activated by cGMP and finally execute the relaxation of penile smooth muscle are not known. Two different cGMP-dependent protein kinases (cGK I and II) have been identified in mammals. Inactivation of cGKI in mice abolished both NO=cGMP-dependent relaxation of vascular and intestinal smooth muscle and inhibition of platelet aggregation, causing hypertension, intestinal dysmotility and abnormal hemostasis. 80 cGKI-deficient mice show a very low ability to reproduce. Corpus cavernosum tissue from these mice has an inability or markedly reduced ability to relax in response to neuronally or endothelially released, or exogenously administered NO. 81 Analysis of the NO=cGMP-induced relaxation clearly showed that cGKI is the major mediator of the cGMP signalling cascade in corpus cavernosum tissue. Its absence cannot be compensated by the cAMP signalling cascade that relaxes normal and cGKInull penile erectile tissue to a similar extent. Taken together, these findings suggest that activation of cGKI is a key step in the signal cascade leading to penile erection.
Vasoactive intestinal polypeptide (VIP) and VIP receptors
The penis of humans as well as animals is richly supplied with nerves containing VIP. 65 The majority of these nerves also contain immunoreactivity to NOS, and colocalization of NOS and VIP within nerves innervating the penis of both animals and humans has been demonstrated by many investigators. It seems that most of these NO-and VIPcontaining neurons are cholinergic, since they also contain VAChT, 66, 67 which is a specific marker for cholinergic neurons. VIP receptors (types 1 and 2), linked via a stimulatory G-protein to adenylyl cyclase, are considered to mediate the actions of the peptide. 82 The importance of the different subtypes of VIP in penile tissues have not been clarified. VIP related peptides, eg pituitary adenylyl cyclase-activating peptide (PACAP), which has been found to be colocalized with VIP in penile nerves, seem to act through one of the VIP receptors. The stimulatory effect of VIP on adenylyl cyclase leads to an increase in cAMP, which in turn activates cAMP-dependent protein kinase.
Undeniably, VIP has an inhibitory and relaxationproducing effect on strips of human corpus cavernosum tissue and cavernosal vessels in vitro, but it has been difficult to convincingly show that VIP released from nerves is responsible for relaxation of penile smooth muscle in vitro or in vivo. 2, 83 Whether or not VIP has a role as a neurotransmitter or modulator of neurotransmission in the penis has not been established. Even if its physiological role in penile erection and in erectile dysfunction remains to be settled, VIP receptors in the penis are an interesting therapeutic target.
Prostanoids and prostanoid receptors
Prostaglandins (PGs) and thromboxanes are locally acting hormones derived from arachidonic acid by the action of cyclooxygenases. Human corpus cavernosum tissue has the ability to synthesise various prostanoids, and has also the ability to locally metabolize them. 2 The production of prostanoids can be modulated by oxygen tension and suppressed by hypoxia. There are five primary active prostanoid metabolites: PGD 2 ; PGE 2 ; PGF 2 ; PGI 2 and TXA 2 , and it has been proposed that there are five major groups of receptors, corresponding to these metabolities, that mediate their effects, namely DP, EP, FP, IP and TP receptors. cDNAs encoding representatives of each of these groups of receptors have been cloned, including several subtypes of EP receptors. The prostanoid receptors are G-proteincoupled receptors with differing transduction systems.
Penile tissues may contain most of these groups of receptors. However, their role in penile physiology is still far from established. Prostanoids may be involved in contraction of erectile tissues via PGF 2a and thromboxane A 2 , stimulating TX and FP receptors and initiating phosphoinositide turnover, as well as in relaxation via PGE 1 and PGE 2 , stimulating EP receptors (EP2=EP4) and initiating an increase in the intracellular concentration of cAMP. Prostanoids may also be involved in inhibition of platelet aggregation and white cell adhesion, and recent data suggest that prostanoids and transforming growth factor-b 1 (TGF-b 1 ) may have a role in modulation of collagen synthesis and in the regulation of fibrosis of the corpus cavernosum. 84 The Rho-A=Rho kinase pathway A major mechanism of Ca 2þ sensitization of smooth muscle contraction is through inhibition of the smooth muscle myosin phosphatase (MLCP). The resulting myosin phosphorylation and subsequent smooth-muscle contraction therefore occurs without a change in sarcoplasmic Ca 2þ concentration. Recent studies have revealed important roles for the small GTPase Rho and its effector, Rho-associated kinase (Rho-kinase) in Ca 2þ -independent regulation of smooth muscle concentration. The Rho -Rhokinase pathway modulates the level of phosphorylation of the myosin light chain of myosin II, mainly through inhibition of myosin phosphatase, and contributes to agonist-induced Ca 2þ -sensitization in smooth muscle concentration. Ca 2þ sensitization by the Rho-A=Rho-kinase pathway contributes to the tonic phase of the agonist-induced contraction in smooth muscle, and abnormally increased activation of myosin by this mechanism may play a role in certain diseases. 85, 86 This calcium-sensitizing RhoA=Rho-kinase pathway may also play a synergistic role in cavernosal vasoconstriction to maintain penile flaccidity. Rho-kinase is known to inhibit myosin light chain phosphatase, and to directly phosphorylate myosin light-chain, altogether resulting in a net increase in activated myosin and the promotion of cellular contraction. Although Rhokinase protein and mRNA have been detected in cavernosal tissue, the role of Rho-kinase in the regulation of cavernosal tone is unknown. Using the Rho-kinase antagonist Y-27632, Wingard et al examined the role of Rho-kinase in cavernosal tone, based on the hypothesis that antagonism of Rhokinase results in increased corpus cavernosum pressure, initiating the erectile response independently of NO. 87 They found that Rho-kinase antagonism stimulated rat penile erection independently of NO, and suggested that this principle could be a potential alternate avenue for the treatment of erectile dysfunction.
Conclusions
The central regulation of the erectile process involves several transmitters, including oxytocin, dopamine, serotonin, ACTH=a-MS and NO, but is still only partly known. Peripherally, the different steps involved in the relaxation of penile vasculature and corpus cavernosum smooth muscle, necessary for erection, need further investigation. Both centrally and peripherally, new targets for therapeutic interventions may still be found.
